Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Emergent BioSolutions Inc
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Find out what a historical investment in Emergent BioSolutions Inc would be worth today using our EBS stock calculator.
Market Capitalisation
$409.67M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
508.2K
High today
$8.18
Low today
$7.91
Open price
$8.10
52-week high
$14.06
52-week low
$5.31
Ready to start your investing journey with Stake?
Open an accountHow do I buy EBS shares in Australia?
Buying EBS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Emergent BioSolutions Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in EBS
What is the ticker symbol of Emergent BioSolutions Inc?
The ticker symbol for Emergent BioSolutions Inc is EBS.
How much is one share of EBS?
One share of EBS is valued at $8.00 as of 16 May 2026.
What is the market capitalisation of Emergent BioSolutions Inc EBS?
As of 16 May 2026 Emergent BioSolutions Inc has a market cap of $409.67M.
What is the 52-week high for Emergent BioSolutions Inc stock?
The Emergent BioSolutions Inc 52-week high stock price is $14.06.
What is the 52-week low for Emergent BioSolutions Inc stock?
The Emergent BioSolutions Inc 52-week low stock price is $5.31.
Can I buy EBS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy EBS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EBS on Stake
- Buy EBS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of EBS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
EBS related stocks